The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
The company's test, CNSDose, incorporates multiple genes involved in metabolism of antidepressants in the liver and how they cross into the brain via the blood-brain-barrier.
Originally published May 15.
Diamond Healthcare will initially provide AssureRx Health's GeneSightRx psychiatric pharmacogenetic test in 10 of its behavioral health units, but plans to expand adoption of PGx testing within its 30-state network.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.